ApprovalTrail

Drug · DIN 02564904

IMULDOSA

SINGLE-USE PREFILLED SYRINGE

Authorized, not yet reported as sold

Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.

Status Approved since January 21, 2026.
Drug Identification Number (DIN)
02564904
Company (DIN owner)
Accord Healthcare IncKirkland, Quebec, Canada
Schedule
Prescription; Schedule D
Dosage form
Solution
Route
Subcutaneous
Therapeutic class (ATC)
Ustekinumab L04AC05
Class
Human
Record last updated
October 6, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
USTEKINUMAB90 MG1 ML

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named IMULDOSA